Roivant Sciences Ltd. ROIV
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 45.73% | -74.30% | -593.91% | -107.77% | -110.36% |
| Total Depreciation and Amortization | -78.28% | -76.21% | -44.80% | -40.20% | -45.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 119.59% | 127.77% | 104.38% | 93.57% | 93.98% |
| Change in Net Operating Assets | -1,257.44% | -707.05% | 114.40% | -128.96% | -132.05% |
| Cash from Operations | 4.06% | 10.61% | 2.10% | 1.12% | -20.17% |
| Capital Expenditure | 40.11% | -78.50% | -87.55% | -444.88% | -294.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -101.30% | -101.30% | -71.62% | -95.71% | -93.46% |
| Other Investing Activities | 121.79% | 68.13% | 104.89% | 110.25% | -39,475.59% |
| Cash from Investing | 124.01% | 61.37% | 107.71% | -71.06% | -154.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -158.52% | -105.95% |
| Issuance of Common Stock | 303.13% | 432.36% | 459.90% | 535.16% | -66.82% |
| Repurchase of Common Stock | 54.12% | 72.44% | 47.82% | 3.51% | -28.02% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 105.22% | 105.22% | -- | -52.76% | -51.53% |
| Cash from Financing | 118.81% | 111.00% | 102.40% | -1.70% | -200.31% |
| Foreign Exchange rate Adjustments | -24.06% | 404.28% | 414.96% | -89.64% | 314.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.27% | 66.15% | 89.05% | -229.06% | -204.74% |